These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
824 related articles for article (PubMed ID: 9528857)
1. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K; Anand G; Yin X; Grove L; Prochownik EV Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857 [TBL] [Abstract][Full Text] [Related]
2. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network. Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719 [TBL] [Abstract][Full Text] [Related]
4. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1. Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639 [TBL] [Abstract][Full Text] [Related]
5. Lack of transcriptional repression by max homodimers. Yin X; Grove L; Prochownik EV Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight inhibitors of Myc-Max interaction and function. Yin X; Giap C; Lazo JS; Prochownik EV Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853 [TBL] [Abstract][Full Text] [Related]
7. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions. Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223 [TBL] [Abstract][Full Text] [Related]
9. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Lüscher B; Larsson LG Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc. Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213 [TBL] [Abstract][Full Text] [Related]
11. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Quéva C; Hurlin PJ; Foley KP; Eisenman RN Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870 [TBL] [Abstract][Full Text] [Related]
12. Design and properties of a Myc derivative that efficiently homodimerizes. Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157 [TBL] [Abstract][Full Text] [Related]
13. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810 [TBL] [Abstract][Full Text] [Related]
14. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max. Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152 [TBL] [Abstract][Full Text] [Related]
17. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Shapiro DN; Valentine V; Eagle L; Yin X; Morris SW; Prochownik EV Genomics; 1994 Sep; 23(1):282-5. PubMed ID: 7829091 [TBL] [Abstract][Full Text] [Related]
18. Gene-target recognition among members of the myc superfamily and implications for oncogenesis. O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054 [TBL] [Abstract][Full Text] [Related]
19. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822 [TBL] [Abstract][Full Text] [Related]
20. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Edelhoff S; Ayer DE; Zervos AS; Steingrímsson E; Jenkins NA; Copeland NG; Eisenman RN; Brent R; Disteche CM Oncogene; 1994 Feb; 9(2):665-8. PubMed ID: 8290278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]